Wealth Enhancement Advisory Services, LLC Day One Biopharmaceuticals, Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $55.6 Billion
- Q2 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 10,262 shares of DAWN stock, worth $76,041. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,262
Previous 11,154
8.0%
Holding current value
$76,041
Previous $88,000
25.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding DAWN
# of Institutions
182Shares Held
69.3MCall Options Held
122KPut Options Held
85.5K-
Atlas Venture Life Science Advisors, LLC6.43MShares$47.6 Million9.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.18MShares$45.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$33.6 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA4.1MShares$30.4 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.72MShares$27.6 Million0.56% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $544M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...